Adaptimmune Therapeutics PLC (ADAP)
1.38
+0.09
(+6.98%)
USD |
NASDAQ |
Jul 26, 16:00
1.42
+0.04
(+2.90%)
After-Hours: 20:00
Adaptimmune Therapeutics 1 Year Total Returns (Daily): 46.59% for July 25, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| July 25, 2024 | 46.59% |
| July 24, 2024 | 31.33% |
| July 23, 2024 | 30.70% |
| July 22, 2024 | 28.57% |
| July 19, 2024 | 12.50% |
| July 18, 2024 | 23.68% |
| July 17, 2024 | 39.86% |
| July 16, 2024 | 40.95% |
| July 15, 2024 | 38.18% |
| July 12, 2024 | 37.55% |
| July 11, 2024 | 32.76% |
| July 10, 2024 | 28.19% |
| July 09, 2024 | 33.33% |
| July 08, 2024 | 28.89% |
| July 05, 2024 | 30.23% |
| July 03, 2024 | 9.37% |
| July 02, 2024 | 13.51% |
| July 01, 2024 | 13.51% |
| June 28, 2024 | 6.92% |
| June 27, 2024 | 8.64% |
| June 26, 2024 | -9.47% |
| June 25, 2024 | -8.85% |
| June 24, 2024 | -7.31% |
| June 21, 2024 | -11.88% |
| June 20, 2024 | -16.08% |
| Date | Value |
|---|---|
| June 18, 2024 | -13.73% |
| June 17, 2024 | -8.14% |
| June 14, 2024 | -2.88% |
| June 13, 2024 | 2.97% |
| June 12, 2024 | 0.00% |
| June 11, 2024 | 5.33% |
| June 10, 2024 | 5.33% |
| June 07, 2024 | -1.92% |
| June 06, 2024 | -4.63% |
| June 05, 2024 | 1.92% |
| June 04, 2024 | -6.48% |
| June 03, 2024 | -0.93% |
| May 31, 2024 | 10.78% |
| May 30, 2024 | -6.48% |
| May 29, 2024 | -9.01% |
| May 28, 2024 | -6.31% |
| May 24, 2024 | -12.50% |
| May 23, 2024 | -17.21% |
| May 22, 2024 | -17.97% |
| May 21, 2024 | -17.56% |
| May 20, 2024 | -16.03% |
| May 17, 2024 | -17.16% |
| May 16, 2024 | -8.40% |
| May 15, 2024 | -10.79% |
| May 14, 2024 | -16.06% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-92.35%
Minimum
Oct 08 2019
767.9%
Maximum
Oct 13 2020
12.25%
Average
-38.94%
Median
Apr 02 2020
1 Year Total Returns (Daily) Benchmarks
| Biodexa Pharmaceuticals Plc | -87.50% |
| NuCana PLC | -81.69% |
| Mereo BioPharma Group PLC | 251.7% |
| Autolus Therapeutics PLC | 59.38% |
| TC BioPharm (Holdings) PLC | -90.65% |